Moreover, elucidating the molecular pathways linking cystatin C to retinal degeneration may open new therapeutic avenues, providing opportunities for targeted interventions aimed at modulating cystatin C-related mechanisms in AMD pathogenesis. This evidence concerns the gene CST3 and retinal degeneration.